Inactive Instrument

Biofermin Pharmaceutical Co., Ltd.

4517

JP3799800002

Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index

September 18, 2017 at 12:00 am EDT

Latest news about Biofermin Pharmaceutical Co., Ltd.

Taisho Pharmaceutical Holdings Co., Ltd. completed the acquisition of remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers.	21-07-26	CI
Taisho Pharmaceutical Holdings Co., Ltd. executed a share exchange agreement to acquire remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers for ¥14.8 billion.	21-05-13	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	17-09-18	CI
Taisho and Takeda Terminate Agreement on the Distribution of Biofermin Pharmaceutical's OTC Drugs and Quasi-Drugs	17-02-01	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to S&P Global BMI Index	16-09-19	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	15-09-21	CI
Takeda Pharmaceutical Company Limited and Taisho Pharmaceutical Co., Ltd. Agrees Conduct Domestic Transactions in Relation to Sale of Products Manufactured by Biofermin Pharmaceutical	13-07-31	CI
Taisho Pharmaceutical Co., Ltd. entered into a share purchase arrangement to acquire an additional 8.14% stake in Biofermin Pharmaceutical Co., Ltd. from Takeda Pharmaceutical Company Limited.	13-07-31	CI
Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to Japan TOPIX Index	13-07-25	CI

Chart Biofermin Pharmaceutical Co., Ltd.

Duration

Period

Chart Biofermin Pharmaceutical Co., Ltd.

More charts

BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and veterinary drugs. Additionally, the Company offers its products to both domestic and overseas markets.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+29.81%	699B
NOVO NORDISK A/S	+25.07%	571B
JOHNSON & JOHNSON	-4.77%	364B
MERCK & CO., INC.	+17.84%	326B
ABBVIE INC.	+3.46%	286B
ASTRAZENECA PLC	+14.68%	236B
NOVARTIS AG	+4.71%	198B
ROCHE HOLDING AG	-12.43%	194B
PFIZER, INC.	-3.77%	154B

Other Pharmaceuticals